Early initiation or ongoing treatment? Interpreting sodium–glucose cotransporter 2 inhibitor use after acute coronary syndrome

Jian Tian
Diabetic Medicine · Wiley · 2026-11-16 · DOI: 10.1111/dme.70533

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles